Rhinovirus, known to be the most frequent cause of the common cold, is the only virus which has seen cases rise in the last week or so compared to Coronavirus, RSV and influenza ...

Cases of another horror winter flu virus are surging across the UK alongside Coronavirus and HMPV, new Government data has shown - with young children most at risk ...

ASU’s Banner Alzheimer’s lab may have discovered a link between a common virus infection and Alzheimer's disease.

A new, streamlined AAV purification process that is both universal and scalable could ease commercialization constraint.

The confidence in Voyager Therapeutics (NASDAQ:VYGR)' stock is further supported by the company's strategic collaborations, ...

The Shanghai-based firm will test the gene therapy candidate in patients between 4 and 9 years old with Duchenne muscular dystrophy.

The partners will adapt Eukarÿs' C3P3 engineered enzyme tech to work with adeno-associated virus vectors to boost biomanufacturing yields.

The goal is to treat familial dysautonomia patients with a single injection.

Additional details on the meeting can be found at the WORLD Symposium website. About Spur Therapeutics Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing ...

Viralgen and Axovia Therapeutics are set to form a partnership to progress the development and manufacturing of an adeno-associated virus vector serotype 9 (AAV9)-based gene therapy for retinal ...

Genethon and Eukarÿs announce a strategic partnership to develop a breakthrough technology to reduce the biomanufacturing cost of gene therapies. Evry, ...